Cargando…

NETest is superior to chromogranin A in neuroendocrine neoplasia: a prospective ENETS CoE analysis

INTRODUCTION: The absence of a reliable, universal biomarker is a significant limitation in neuroendocrine neoplasia (NEN) management. We prospectively evaluated two CgA assays, (NEOLISA, EuroDiagnostica) and (CgA ELISA, Demeditec Diagnostics (DD)) and compared the results to the NETest. METHODS: NE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malczewska, Anna, Oberg, Kjell, Kos-Kudla, Beata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923057/ https://www.ncbi.nlm.nih.gov/pubmed/33289691 http://dx.doi.org/10.1530/EC-20-0417

Ejemplares similares

The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
por: Malczewska, Anna, et al.
Publicado: (2019)

NETest liquid biopsy is diagnostic of small intestine and pancreatic neuroendocrine tumors and correlates with imaging
por: Malczewska, Anna, et al.
Publicado: (2019)

Molecular identification of bronchopulmonary neuroendocrine tumours and neuroendocrine genotype in lung neoplasia using the NETest liquid biopsy
por: Filosso, Pier Luigi, et al.
Publicado: (2020)

ENETS standardized (synoptic) reporting for radiological imaging in neuroendocrine tumours
por: Dromain, Clarisse, et al.
Publicado: (2021)

The NETest liquid biopsy is diagnostic for gastric neuroendocrine tumors: observations on the blood-based identification of microscopic and macroscopic residual diseaseOK
por: Malczewska, A., et al.
Publicado: (2020)

Evaluation of circulating transcript analysis (NETest) in small intestinal neuroendocrine neoplasms after surgical resection
por: Laskaratos, Faidon-Marios, et al.
Publicado: (2020)

Selected Serum Biomarkers (Leptin, Chromogranin A, CA19-9, CEA) in Patients with Pancreatic Neuroendocrine Neoplasm and Associations with Metabolic Syndrome
por: Rosiek, Violetta, et al.
Publicado: (2023)

The Risk of Venous Thromboembolism in Neuroendocrine Neoplasms
por: Wójcik-Giertuga, Monika, et al.
Publicado: (2023)

ENETS standardized (synoptic) reporting for neuroendocrine tumour pathology
por: van Velthuysen, Marie‐Louise F., et al.
Publicado: (2022)

Assessment of the Role of Leptin and Adiponectinas Biomarkers in Pancreatic Neuroendocrine Neoplasms
por: Bocian-Jastrzębska, Agnes, et al.
Publicado: (2023)

ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours
por: Srirajaskanthan, Rajaventhan, et al.
Publicado: (2013)

Treatment of neuroendocrine tumors: new recommendations based on the CLARINET study
por: Kos-Kudła, Beata
Publicado: (2015)

NETest: serial liquid biopsies in gastroenteropancreatic NET surveillance
por: van Treijen, Mark J C, et al.
Publicado: (2022)

Functional and non-functional pancreatic neuroendocrine tumours: ENETS or AJCC TNM staging system?
por: Yang, Min, et al.
Publicado: (2017)

CoE RAISE: Enabling AI on HPC systems
por: Wulff, Eric
Publicado: (2023)

Role of Leptin and Adiponectin in Carcinogenesis
por: Bocian-Jastrzębska, Agnes, et al.
Publicado: (2023)

ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Functional Pancreatic Endocrine Tumor Syndromes
por: Jensen, Robert T., et al.
Publicado: (2012)

European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease
por: Grozinsky‐Glasberg, Simona, et al.
Publicado: (2022)

Definition of Classes of Evidence (CoE) and Overall Strength of Evidence (SoE)
Publicado: (2014)

Definition of Classes of Evidence (CoE) and Overall Strength of Evidence (SoE)
Publicado: (2013)

Significance of chromogranin A and synaptophysin in pancreatic neuroendocrine tumors
por: Tomita, Tatsuo
Publicado: (2020)

Pro-Gastrin-Releasing Peptide as a Biomarker in Lung Neuroendocrine Neoplasm
por: Rosiek, Violetta, et al.
Publicado: (2023)

Group photo of the participants in CoE RAISE ALL-Hands Meeting
por: Cavazza, Marina
Publicado: (2023)

Class of evidence (CoE): how does it relate to critical appraisal?
por: Skelly, Andrea C.
Publicado: (2012)

Mr. Robert William Coe
Publicado: (1910)

Dr. Coe and the Octopus Management
Publicado: (1908)

Comparison of PCR-based detection of chromogranin A mRNA with traditional histological lymph node staging of small intestinal neuroendocrine neoplasia
por: Lawrence, Ben, et al.
Publicado: (2012)

Neuron-specific enolase and chromogranin A as markers of neuroendocrine tumours.
por: Baudin, E., et al.
Publicado: (1998)

Clinical Usefulness of Plasma Chromogranin A in Pancreatic Neuroendocrine Neoplasm
por: Paik, Woo Hyun, et al.
Publicado: (2013)

Image Segmentation Technology Based on Attention Mechanism and ENet
por: Ma, Ling, et al.
Publicado: (2022)

An ENet Semantic Segmentation Method Combined with Attention Mechanism
por: Bai, Wei
Publicado: (2023)

LanroNET, a non-interventional, prospective study to assess the resource utilization and cost of lanreotide autogel 120 mg in Polish patients with neuroendocrine tumors – results of interim analysis
por: Orlewska, Ewa, et al.
Publicado: (2014)

Comparison of the prognostic values of the 2010 WHO classification, AJCC 7th edition, and ENETS classification of gastric neuroendocrine tumors
por: Kim, Beom Su, et al.
Publicado: (2016)

Role of Selected Circulating Tumor Biomarkers in Patients with Skeletal Metastatic Pancreatic Neuroendocrine Neoplasms
por: Rosiek, Violetta, et al.
Publicado: (2023)

Chromogranin A: From Laboratory to Clinical Aspects of Patients with Neuroendocrine Tumors
por: Di Giacinto, Paola, et al.
Publicado: (2018)

Limited Diagnostic Utility of Chromogranin A Measurements in Workup of Neuroendocrine Tumors
por: Baekdal, Jonas, et al.
Publicado: (2020)

Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification
por: Brunner, Stefan M, et al.
Publicado: (2015)

TNM Staging of Pancreatic Neuroendocrine Tumors: An Observational Analysis and Comparison by Both AJCC and ENETS Systems From 1 Single Institution
por: Yang, Min, et al.
Publicado: (2015)

Retracted: Image Segmentation Technology Based on Attention Mechanism and ENet
por: Intelligence and Neuroscience, Computational
Publicado: (2023)

Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues
por: Rosiek, Violetta, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e1ul5ftgtfs4dbp7h398m110rs